Metabolic Engineering of Yeast for Polyketide Production

Information

  • Research Project
  • 6519837
  • ApplicationId
    6519837
  • Core Project Number
    R44GM056575
  • Full Project Number
    5R44GM056575-03
  • Serial Number
    56575
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1998 - 26 years ago
  • Project End Date
    4/30/2004 - 20 years ago
  • Program Officer Name
    JONES, WARREN
  • Budget Start Date
    5/1/2002 - 22 years ago
  • Budget End Date
    4/30/2004 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    3
  • Suffix
  • Award Notice Date
    5/2/2002 - 22 years ago
Organizations

Metabolic Engineering of Yeast for Polyketide Production

DESCRIPTION (provided by applicant): The polyketides are a diverse group of natural products with great clinical importance. A major barrier to the high level production of both natural and genetically engineered polyketides has been the lack of a generic heterologous system that (a) functionally expresses the polyketide synthase and accessory enzymes and (b) contains adequate levels of acyl-Coenzyme A substrates. The long term goal of this project is to construct strains of Saccharomyces cerevisiae optimized for polyketide overproduction. In Phase I, we showed that a fungal polyketide could be produced at extremely high levels in S. cerevisiae. We also demonstrated that the three genes for the polyketide precursor of erythromycin could be functionally expressed from separate plasmids in a heterologous Streptomyces host. In Phase II of the project we will: (a) Develop yeast host strains that (i) produce substrates and post-translational enzymes necessary to produce modular polyketides; (ii) have necessary nutritional deficiencies to allow positive selection of at least three compatible plasmids; and (iii) will permit radioactive labeling of -CoA pools and polyketide synthases. (b) Demonstrate that such a strain can express a modular polyketide synthase and produce a complex polyketide at levels suitable for commercial development. PROPOSED COMMERCIAL APPLICATION: A generic overproducing yeast strain will enable production of commercially valuable polyketides with significant cost and time savings over existing native host organisms and production methods.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    375000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:375000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    KOSAN BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
    932981319
  • Organization City
    HAYWARD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94545
  • Organization District
    UNITED STATES